Lloyd D. Fricker

Affiliations: 
Yeshiva University, New York, NY, United States 
Area:
Neuroscience Biology, Pharmacology, Biochemistry
Google:
"Lloyd Fricker"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lindberg I, Fricker LD. (2021) Obesity, POMC, and POMC-processing enzymes: surprising results from animal models. Endocrinology
Garcia-Pardo J, Tanco S, Garcia-Guerrero MC, et al. (2020) Substrate Specificity and Structural Modeling of Human Carboxypeptidase Z: A Unique Protease with a Frizzled-Like Domain. International Journal of Molecular Sciences. 21
Fricker LD, Tashima AK, Fakira AK, et al. (2020) Neuropeptidomic Analysis of a Genetically Defined Cell Type in Mouse Brain and Pituitary. Cell Chemical Biology
Fricker LD, Margolis E, Gomes I, et al. (2020) Five decades of research on opioid peptides: Current knowledge and unanswered questions. Molecular Pharmacology
Fricker LD. (2019) Proteasome Inhibitor Drugs. Annual Review of Pharmacology and Toxicology
Fritz R, Mukherjee A, Zaghi S, et al. (2019) Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility. Journal of Assisted Reproduction and Genetics
Dasgupta S, Fishman MA, Castro LM, et al. (2019) Effect of Protein Denaturation and Enzyme Inhibitors on Proteasomal-Mediated Production of Peptides in Human Embryonic Kidney Cells. Biomolecules. 9
Fricker LD. (2018) Affinity Purification of Neuropeptide Precursors from Mice Lacking Carboxypeptidase E Activity. Methods of Molecular Biology. 1719: 199-208
Dasgupta S, Castro LM, Tashima AK, et al. (2018) Quantitative Peptidomics Using Reductive Methylation of Amines. Methods in Molecular Biology (Clifton, N.J.). 1719: 161-174
Fricker LD. (2018) Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets. Advances in Pharmacology (San Diego, Calif.). 82: 85-102
See more...